Drug Approvals
Drug approvals from official government data, for the US and 13 other countries (country filter). US: every original approval of a new drug, a biologic (including vaccines, blood products, allergenics and cell and gene therapies) or a generic drug, tentative approvals of generics, and every approval of a new use for a drug already on the market (for example a new indication). Each approval has the brand and generic names, the kind of approval, the review priority, a novel drug flag and the listed company that holds the drug today.
All filters are optional and can be combined. The answer is {country, total, limit, offset, sort, order, data_as_of, rows, ignored, about}. Rows of other countries carry date_precision (year when only the year is published, so no day is shown) and approval_id for the detail endpoint. US rows also carry center, product_category, name_source (set when a missing name was filled in from other official data) and note. The demo key works with symbol=AAPL, MSFT or WMT.
Request
- Base URL: https://api.dataporium.io
- URL: https://api.dataporium.io/drug-approvals
- Auth: API key in query parameter apikey
Query parameters
US (default) or a country code from /drug-approvals/countries, for example EU, GB, JP, CN, CA. Other countries have the fields they publish; filters they cannot use are listed in the answer under ignored
Ticker(s) of the listed company, comma-separated
Words in the brand name, generic name or holder name
Words in the generic (active ingredient) name
Words in the holder or company name
Approved in this year or later
Approved in this year or earlier
US: new_drug, biologic or generic. Other countries: drug, generic, biologic, biosimilar, vaccine, atmp or otc. Comma-separated
priority or standard (countries that publish review speed)
US: kind of approval as in category. Other countries: route code such as full_new_active or generic
US only: words in the dosage form
US: vaccine, blood product, allergenic, gene therapy, cell therapy, tissue product or other biologic
US: CDER (drugs and most biologics) or CBER (vaccines, blood products, allergenics, cell and gene therapies)
US: true = only approvals that have no brand and no generic name yet
NDA, BLA or ANDA; comma-separated
original or supplement (a new use)
approved or tentative
true = only novel drugs
true = only approvals with a priority review
Kind of approval, e.g. New molecular entity, Generic drug
true = only drugs of listed companies
Approved on or after (YYYY-MM-DD)
Approved on or before (YYYY-MM-DD)
Only approvals from the last N days
approval_date (default), brand_name, generic_name, symbol, holder_name, application_number, type, kind, review or form (form: US only). Sorting is done on the whole list, not on the page
asc or desc
Rows per page, 1 to 1000 (default 50)
Rows to skip, for paging
Response
Successful response (JSON).
Changes
No recorded changes to this operation across all 1 revision of this API.